Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 601

1.

Response to the Comment on "Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in Aninternational Cohort".

Zheng J, Chapman WC, Turcotte S, Koerkamp BG, Lee SY, Jarnagin WR.

Ann Surg. 2019 Mar;269(3):e34-e35. doi: 10.1097/SLA.0000000000002871. No abstract available.

PMID:
30724808
2.

Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.

Narayan RR, Goldman DA, Gonen M, Reichel J, Huberman KH, Raj S, Viale A, Kemeny NE, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Jarnagin WR, Kingham TP.

Ann Surg Oncol. 2019 Jan 31. doi: 10.1245/s10434-019-07201-5. [Epub ahead of print]

PMID:
30706231
3.

Pilot study of rapid MR pancreas screening for patients with BRCA mutation.

Corrias G, Raeside MC, Agostini A, Huicochea-Castellanos S, Aramburu-Nunez D, Paudyal R, Shukla-Dave A, Smelianskaia O, Capanu M, Zheng J, Fung M, Kelsen DP, Mangino DA, Robson ME, Goldfrank DJ, Carter J, Allen PJ, Conti B, Monti S, Do RKG, Mannelli L.

Eur Radiol. 2019 Jan 28. doi: 10.1007/s00330-018-5975-0. [Epub ahead of print]

PMID:
30689033
4.

Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.

Pak LM, Gagnière J, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Miga MI, Simpson AL, Kingham TP.

J Gastrointest Surg. 2019 Jan 24. doi: 10.1007/s11605-019-04106-2. [Epub ahead of print]

PMID:
30680630
5.

Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities.

Balachandran VP, Beatty GL, Dougan SK.

Gastroenterology. 2019 Jan 17. pii: S0016-5085(19)30054-X. doi: 10.1053/j.gastro.2018.12.038. [Epub ahead of print]

PMID:
30660727
6.

Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study.

Lawrence SA, McIntyre CA, Pulvirenti A, Seier K, Chou Y, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Jan 8. pii: S1072-7515(19)30015-8. doi: 10.1016/j.jamcollsurg.2018.12.018. [Epub ahead of print]

PMID:
30630087
7.

Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.

Wong W, Lowery MA, Berger MF, Kemel Y, Taylor B, Zehir A, Srinivasan P, Bandlamudi C, Chou J, Capanu M, Varghese A, Yu KH, Iacobuzio-Donahue CA, Shia J, Klimstra DS, Jarnagin WR, Stadler ZK, O'Reilly EM.

Cancer. 2019 Jan 8. doi: 10.1002/cncr.31951. [Epub ahead of print]

PMID:
30620386
8.

Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities.

Olasehinde O, Alatise OI, Arowolo OA, Mango VL, Olajide OS, Omisore AD, Boutin-Foster C, Kingham TP.

Eur J Cancer Care (Engl). 2019 Jan 6:e12986. doi: 10.1111/ecc.12986. [Epub ahead of print]

PMID:
30614109
9.

Fast and accurate vision-based stereo reconstruction and motion estimation for image-guided liver surgery.

Speers AD, Ma B, Jarnagin WR, Himidan S, Simpson AL, Wildes RP.

Healthc Technol Lett. 2018 Oct 19;5(5):208-214. doi: 10.1049/htl.2018.5071. eCollection 2018 Oct.

10.

Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.

Narayan RR, Creasy JM, Goldman DA, Gönen M, Kandoth C, Kundra R, Solit DB, Askan G, Klimstra DS, Basturk O, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Kingham TP, Simpson AL, Abou-Alfa GK, Harding JJ, O'Reilly EM, Butte JM, Matsuyama R, Endo I, Jarnagin WR.

Cancer. 2019 Feb 15;125(4):575-585. doi: 10.1002/cncr.31850. Epub 2018 Nov 14.

PMID:
30427539
11.

Laparoscopic Liver Resection Difficulty Score-a Validation Study.

Lee SY, Goh BKP, Sepideh G, Allen JC, Merkow RP, Teo JY, Chandra D, Koh YX, Tan EK, Kam JH, Cheow PC, Chow PKH, Ooi LLPJ, Chung AYF, D'Angelica MI, Jarnagin WR, Peter Kingham T, Chan CY.

J Gastrointest Surg. 2018 Nov 12. doi: 10.1007/s11605-018-4036-y. [Epub ahead of print]

PMID:
30421119
12.

Minimally Invasive Staging Surgery for Cancer.

Cohen NA, Kingham TP.

Surg Oncol Clin N Am. 2019 Jan;28(1):61-77. doi: 10.1016/j.soc.2018.07.006. Epub 2018 Oct 23. Review.

PMID:
30414682
13.

Outcomes after Pancreatectomy with Routine Pasireotide Use.

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Feb;228(2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. Epub 2018 Nov 7.

PMID:
30414453
14.

Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):395. doi: 10.1007/s00268-018-4845-x.

PMID:
30406321
15.

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, Do RK, Sun Y, Kingham TP, D'Angelica MI, Berger MF, Hyman DM, Jarnagin W, Klimstra DS, Janjigian YY, Solit DB, Schultz N, Abou-Alfa GK.

Clin Cancer Res. 2018 Oct 29. doi: 10.1158/1078-0432.CCR-18-2293. [Epub ahead of print]

PMID:
30373752
16.

Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors.

Pulvirenti A, Rao D, Mcintyre CA, Gonen M, Tang LH, Klimstra DS, Fleisher M, Ramanathan LV, Reidy-Lagunes D, Allen PJ.

HPB (Oxford). 2018 Oct 23. pii: S1365-182X(18)34466-6. doi: 10.1016/j.hpb.2018.09.016. [Epub ahead of print]

PMID:
30366884
17.

Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study.

Nota CL, Woo Y, Raoof M, Boerner T, Molenaar IQ, Choi GH, Kingham TP, Latorre K, Borel Rinkes IHM, Hagendoorn J, Fong Y.

Ann Surg Oncol. 2019 Feb;26(2):583-590. doi: 10.1245/s10434-018-6928-1. Epub 2018 Oct 17.

PMID:
30334196
18.

ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms.

Al Efishat M, Allen PJ.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):822-823. doi: 10.1245/s10434-018-6915-6. Epub 2018 Oct 15. No abstract available.

PMID:
30324467
19.

Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection.

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Covey AM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Gerdes H, Allen PJ, Schattner MA.

HPB (Oxford). 2018 Oct 4. pii: S1365-182X(18)33940-6. doi: 10.1016/j.hpb.2018.08.010. [Epub ahead of print]

PMID:
30293867
20.

CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas.

Chakraborty J, Midya A, Gazit L, Attiyeh M, Langdon-Embry L, Allen PJ, Do RKG, Simpson AL.

Med Phys. 2018 Nov;45(11):5019-5029. doi: 10.1002/mp.13159. Epub 2018 Sep 27.

PMID:
30176047

Supplemental Content

Loading ...
Support Center